Trademark: 88749349
Status Date
Monday, August 14, 2023
Filing Date
Tuesday, January 7, 2020
Published for Opposition
Tuesday, May 19, 2020
Abandoned Date
Monday, August 14, 2023
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders
Aug 14, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 14, 2023
Abandonment - No Use Statement Filed
Jun 29, 2023
Assigned To Examiner
Feb 2, 2023
Teas Change Of Correspondence Received
Feb 2, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 2, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 2, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2023
Sou Extension 5 Granted
Jan 9, 2023
Sou Extension 5 Filed
Jan 25, 2023
Case Assigned To Intent To Use Paralegal
Jan 9, 2023
Sou Teas Extension Received
Jul 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2022
Sou Extension 4 Granted
Jul 14, 2022
Sou Extension 4 Filed
Jul 14, 2022
Sou Teas Extension Received
Jul 7, 2022
Teas Change Of Correspondence Received
Jul 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 6, 2022
Sou Extension 3 Granted
Jan 6, 2022
Sou Extension 3 Filed
Jan 6, 2022
Sou Teas Extension Received
Jul 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2021
Sou Extension 2 Granted
Jul 13, 2021
Sou Extension 2 Filed
Jul 13, 2021
Sou Teas Extension Received
Dec 18, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2020
Sou Extension 1 Granted
Dec 16, 2020
Sou Extension 1 Filed
Dec 16, 2020
Sou Teas Extension Received
Jul 14, 2020
Noa E-Mailed - Sou Required From Applicant
May 19, 2020
Official Gazette Publication Confirmation E-Mailed
May 19, 2020
Published For Opposition
Apr 29, 2020
Notification Of Notice Of Publication E-Mailed
Apr 10, 2020
Assigned To Lie
Apr 3, 2020
Approved For Pub - Principal Register
Apr 1, 2020
Examiner's Amendment Entered
Apr 1, 2020
Notification Of Examiners Amendment E-Mailed
Apr 1, 2020
Examiners Amendment E-Mailed
Apr 1, 2020
Examiners Amendment -Written
Mar 27, 2020
Notification Of Non-Final Action E-Mailed
Mar 27, 2020
Non-Final Action E-Mailed
Mar 27, 2020
Non-Final Action Written
Mar 26, 2020
Assigned To Examiner
Jan 10, 2020
New Application Office Supplied Data Entered
Jan 10, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
